Target intelligence / Profile preview

Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH)

Target
PIGH
Molecular classification
Enzyme
01

Overview

Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH) is an endoplasmic reticulum-associated enzyme component required for the biosynthesis of glycosylphosphatidylinositol (GPI) anchors[1][3][7][8][9]. This subunit is part of the GPI N-acetylglucosaminyl (GlcNAc) transferase complex, which catalyzes the transfer of N-acetylglucosamine (GlcNAc) to phosphatidylinositol (PI), the first step in GPI anchor biosynthesis[1][3][7][8][9]. GPI anchors tether a wide range of proteins—critical for neuronal development, embryogenesis, and immune signaling—to the cell surface. Genetic variants or silencing of PIGH impair GPI anchor formation and surface display of GPI-anchored proteins, leading to neurological, developmental, and immune dysfunction, as well as resistance to some targeted therapies in hematologic malignancies[1][3][7].

Other names
Phosphatidylinositol glycan anchor biosynthesis class HPIGHGPI-HPhosphatidylinositol-glycan biosynthesis class H protein
02

Biological functions

Glycosylphosphatidylinositol (GPI) anchor biosynthesisCell surface protein anchoringEmbryogenesisImmune signalingNeuronal function
03

Disease associations

Neurodevelopmental disorders (e.g., epilepsy, intellectual disability, autism)Developmental defectsHematological disease (e.g., resistance to immunotherapy in B-cell acute lymphoblastic leukemia)
04

Safety considerations

Mutations or epigenetic silencing may lead to loss of cell surface GPI-anchored proteins, with neurological, developmental, and hematological consequences[1]
05

Biomarkers

Loss of GPI-anchored markers such as CD52 for monitoring GPI-anchor defects in hematologic malignancies[1]

Beyond the preview

Go deeper on Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call